Evidence map›Paper›PMID 42909256›Full record

ArticleFrontiers in oncology2026

Knowledge, willingness, and reported prior prostate cancer testing among men in Palestine: a cross-sectional online survey.

Karam Salama, Islam Staiti, Moath Hammad, Said Abu-Hajleh, Ahmed Mousa, Baha Kamel, Ahmad Salah, Osaid Heleseh, Aktham Al-Safi, Bashar Al Jaraysa and 6 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Karam SalamaFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Islam StaitiResearch Scope, Hebron, Palestine.
Moath HammadResearch Scope, Hebron, Palestine.
Said Abu-HajlehResearch Scope, Hebron, Palestine.
Ahmed MousaResearch Scope, Hebron, Palestine.
Baha KamelResearch Scope, Hebron, Palestine.
Ahmad SalahResearch Scope, Hebron, Palestine.
Osaid HelesehResearch Scope, Hebron, Palestine.
Aktham Al-SafiResearch Scope, Hebron, Palestine.
Bashar Al JaraysaFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Bashar JamalFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Momen AbuSaadaResearch Scope, Hebron, Palestine.
Majd Marwan ZaghalFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Salahaldeen DeebFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Alhareth M AmroFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Mustafa NakhalaFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evidence on prostate cancer (PCa) knowledge and PSA-related testing behavior in Palestine remains limited. We assessed general awareness, factual knowledge, willingness to undergo PSA testing if offered, reported prior PSA testing/prostate examination, and factors associated with prior testing. Methods: We conducted a cross-sectional online survey from 19 November to 21 December 2025 among adult men aged 18 years or older recruited from Palestinian communities. The full cohort comprised 1,047 consenting participants. The exported dataset contained two incompatible response formats for the 12 factual knowledge items; composite knowledge analyses were therefore limited to 568 respondents with complete, unambiguous single Yes/No responses. Knowledge was scored from 0 to 12 using the study answer key. Willingness and prior testing were analyzed as binary outcomes. Multivariable logistic regression assessed factors associated with prior testing. Results: Mean age was 28.7 ± 12.4 years and 78.6% were aged 18-39 years. Overall, 80.0% had heard of PCa, 26.1% had heard of PSA testing, 31.2% were willing to undergo PSA testing if offered, and 5.6% reported prior PSA testing and/or prostate examination. Among the 568 scorable knowledge respondents, mean knowledge was 7.07 ± 1.84 of 12 and 89.1% had limited knowledge (<80% correct); KR-20 was 0.235. Adequate knowledge was associated with lower willingness (12.9% vs 32.8%; p=0.002) but not prior testing (3.2% vs 6.1%; p=0.526). In the full cohort, older age (aOR 1.08 per year; 95% CI 1.05-1.10), healthcare background (aOR 2.10; 95% CI 1.17-3.77), and first-degree family history (aOR 2.22; 95% CI 1.01-4.86) were independently associated with prior testing. Among never-tested participants, the leading reported barriers were low perceived personal risk (55.3%) and lack of physician/healthcare-provider recommendation (43.1%); multiple responses were allowed. Conclusions: In this predominantly young online sample, general awareness exceeded detailed factual knowledge, while willingness and reported prior testing were low. The divergence between knowledge and behavior should be interpreted cautiously because knowledge analyses used a restricted subset and the shortened scale had low internal consistency. Findings support culturally appropriate, risk-adapted clinician-patient communication and further validation of locally adapted measurement tools.

Indexed as

knowledgePalestineprostate cancerprostate-specific antigenPSA testingshared decision-making

Identifiers

PMID42909256
PMCPMC13683944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.